Biokraft International AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 123.1 million compared to SEK 97.01 million a year ago. Revenue was SEK 137.84 million compared to SEK 107.63 million a year ago. Net loss was SEK 58.24 million compared to SEK 15.17 million a year ago. Basic loss per share from continuing operations was SEK 1.31 compared to SEK 0.32 a year ago.
For the full year, sales was SEK 469.41 million compared to SEK 387.1 million a year ago. Revenue was SEK 534.13 million compared to SEK 407.44 million a year ago. Net loss was SEK 160.11 million compared to SEK 81.9 million a year ago. Basic loss per share from continuing operations was SEK 3.65 compared to SEK 1.95 a year ago.